Table 3.
Estimated mean difference in blood pressure associated with 2 SD higher intakes of total fibre, insoluble fibre and soluble fibre in US INTERMAP participants, excluding those with hypertension and users of antihypertensive drugs
(Mean differences and 95% confidence intervals; n 1477)*
SBP (mmHg) |
DBP (mmHg) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Not adjusted for BMI |
Adjusted for BMI |
Not adjusted for BMI |
Adjusted for BMI |
|||||||||
Model | Difference | 95 % CI | P | Difference | 95 % CI | P | Difference | 95 % CI | P | Difference | 95% CI | P |
Total fibre | ||||||||||||
Model 1 | −3·50 | −4·80,−2·20 | <0·0001 | −3·45 | −4·74, −2·16 | <0·0001 | −2·01 | −2·95, −1·06 | <0·0001 | −1·47 | −2·37, −0·56 | 0·002 |
Model 2 | −2·76 | −4·11, −1·40 | <0·0001 | −1·82 | −3·10, −0·54 | 0·01 | −1·77 | −2·75, −0·78 | 0·0004 | −1·19 | −2·13, −0·24 | 0·01 |
Model 3 | −2·77 | −4·12, −1·43 | <0·0001 | −1·85 | −3·13, −0·57 | 0·005 | −1·78 | −2·75, −0·80 | 0·0004 | −1·19 | −2·14, −0·25 | 0·01 |
Model 4 | −3·06 | −4·44, −1·68 | <00001 | −2·05 | −3·36, −0·74 | 0·002 | −1·87 | −2·87, −0·87 | 0·0003 | −1·24 | −2·20, −0·27 | 0·01 |
Model 5 | −2·70 | −4·05, −1·35 | <0·0001 | −1·79 | −3·07, −0·52 | ·001 | −1·73 | −2·71, −0·76 | 0·001 | −1·17 | −2·11, −0·23 | 0·02 |
Model 6 | −3·02 | −4·43, −1·60 | <0·0001 | −1·69 | −3·04, −0·34 | 0·014 | −1·96 | −2·99, −0·93 | 0·0002 | −1·15 | −2·14, −0·15 | 0·02 |
Insoluble fibre† | ||||||||||||
Model 1 | −3·80 | −5·80, −1·79 | 0·0002 | −3·08 | −4·98, −1·19 | 0·001 | −2·90 | −4·36, −1·45 | <0·0001 | −2·46 | −3·85, −1·06 | 0·001 |
Model 2 | −3·29 | −5·30, −1·28 | 0·001 | −2·54 | −4·44, −0·65 | 0·01 | −2·60 | −4·05, −1·14 | 0·001 | −2·13 | −3·53, −0·74 | 0·003 |
Model 3 | −3·15 | −5·15, −1·15 | 0·002 | −2·52 | −4·42, −0·63 | 0·01 | −2·52 | −3·97, −1·07 | 0·001 | −2·13 | −3·52, −0·73 | 0·003 |
Model 4 | −3·51 | −5·53, −1·50 | 0·001 | −2·71 | −4·62, −0·81 | 0·01 | −2·67 | −4·14, −1·21 | 0·0004 | −2·18 | −3·58, −0·77 | 0·002 |
Model 5 | −3·25 | −5·25, −1·25 | 0·002 | −2·52 | −4·41, −0·63 | 0·01 | −2·57 | −4·03, −1·12 | 0·001 | −2·12 | −3·52, −0·73 | 0·003 |
Model 6 | −3·37 | −5·39, −1·36 | 0·001 | −2·48 | −4·38, −0·58 | 0·01 | −2·66 | −4·12, −1·20 | 0·0004 | −2·11 | −3·51, −0·71 | 0·003 |
Soluble fibre‡ | ||||||||||||
Model 1 | 0·33 | −1·66, 2·32 | 0·74 | 0·36 | −1·51, 2·23 | 0·70 | 0·88 | −0·56, 2·32 | 0·23 | 0·90 | −0·48, 2·28 | 0·20 |
Model 2 | 0·68 | −1·30, 2·66 | 0·50 | 0·79 | −1·07, 2·66 | 0·41 | 0·82 | −0·62, 2·26 | 0·26 | 0·89 | −0·49, 2·26 | 0·21 |
Model 3 | 0·48 | −1·50, 2·45 | 0·64 | 0·74 | −1·13, 2·60 | 0·44 | 0·71 | −0·72, 2·14 | 0·33 | 0·87 | −0·51, 2·25 | 0·22 |
Model 4 | 0·63 | −1·35, 2·61 | 0·54 | 0·75 | −1·11, 2·61 | 0·43 | 0·80 | −0·64, 2·24 | 0·27 | 0·88 | −0·50, 2·25 | 0·21 |
Model 5 | 0·72 | −1·25, 2·69 | 0·47 | 0·82 | −1·04, 2·68 | 0·39 | 0·84 | −0·59, 2·27 | 0·25 | 0·90 | −0·47, 2·28 | 0·20 |
Model 6 | 0·55 | −1·45, 2·55 | 0·59 | 0·89 | −0·99, 2·77 | 0·35 | 0·71 | −0·74, 2·16 | 0·34 | 0·92 | −0·47, 2·31 | 0·19 |
DBP, diastolic blood pressure; SBP, systolic blood pressure.
2 SD fibres (g/4184 kJ (g/1000 kcal)) total fibre (6·9); insoluble fibre (4·8); soluble fibre (2·2). Model 1 was adjusted for age, gender, total energy (kJ/24 h (kcal/24 h)), total protein (% energy), total fat (% energy), total sugar (% energy) and population sample. Model 2 was adjusted as model 1 variables plus adherence to energy-restricted diet, smoking, alcohol intake (g/24 h), hours engaged in moderate and heavy physical activity, dietary supplement use, educational level, CVD or diabetes diagnosis and family history of high blood pressure. Model 3 was adjusted as model 2 plus urinary Na (mmol/24 h). Model 4 was adjusted as model 2 plus urinary Mg (mmol/24 h). Model 5 was adjusted as model 2 plus urinary calcium (mmol/24 h). Model 6 was adjusted as model 2 plus urinary K (mmol/24 h).
Additionally adjusted for soluble fibre (g/4184 kJ (g/1000 kcal)).
Additionally adjusted for insoluble fibre (g/4184 kJ (g/1000 kcal)).